Klemi Pekka J, Parvinen Ilmo, Pylkkänen Liisa, Kauhava Lea, Immonen-Räihä Pirjo, Räsänen Osmo, Helenius Hans
Department of Pathology, Turku University Hospital, FIN-20520 Turku, Finland.
Breast. 2003 Oct;12(5):308-13. doi: 10.1016/s0960-9776(03)00096-1.
The purpose of this study was to evaluate the effect of population-based mammography screening on survival. A total of 176 908 screening examinations were performed in 36 000 women aged 40-74 during the years 1987-1997. Screen-detected and interval primary invasive breast cancers (n=685, screened) were more often smaller (P<0.0001), localised (P<0.0001) and histologically better differentiated (grade I vs II-III, P<0.0001) than pre-screening cancers and cancers detected after the defined interval from the last screening (n=184, clinical). Survival was far better in the "screened" group than in the "clinical" group (P<0.0001, HR 2.55; CI 95% 1.77-3.67). Cox's multivariate analysis revealed axillary lymph node negativity (P<0.0001), histological grade I (P=0.0005) and size less than or equal to 20mm (P=0.0118) as explanations of the beneficial effect of screening. A new observation we recorded was that screening had a beneficial effect even in women whose cancer had already spread into the axillary lymph nodes.
本研究的目的是评估基于人群的乳腺钼靶筛查对生存的影响。1987年至1997年间,对36000名年龄在40 - 74岁的女性进行了总计176908次筛查。与筛查前癌症以及在最后一次筛查规定间隔后检测出的癌症(临床组,n = 184)相比,筛查发现的和间隔期原发性浸润性乳腺癌(筛查组,n = 685)往往体积更小(P < 0.0001)、定位更局限(P < 0.0001)且组织学分化更好(I级与II - III级相比,P < 0.0001)。“筛查组”的生存率远高于“临床组”(P < 0.0001,HR 2.55;95% CI 1.77 - 3.67)。Cox多因素分析显示腋窝淋巴结阴性(P < 0.0001)、组织学I级(P = 0.0005)以及大小小于或等于20mm(P = 0.0118)可解释筛查的有益效果。我们记录的一项新观察结果是,即使对于癌症已扩散至腋窝淋巴结的女性,筛查也具有有益效果。